Dr. Reddy's Laboratories (RDY) Financial Statements & Analysis

Dr. Reddy's Laboratories (RDY) Income Statement

Dr. Reddy's Laboratories reported revenue of INR 335.93B in fiscal 2026 (fiscal year ended Mar 31, 2026), up 3.2% from INR 325.54B a year earlier. Net income was INR 42.85B, down 24.2% year over year, a net margin of 12.8%. Gross margin was 52.8% and operating margin 14.9%. In the most recent quarter, Q1 fiscal 2027 (ended Jun 30, 2026), revenue was INR 80.70B, down 5.6% from the same quarter a year earlier.

Dr. Reddy's Laboratories Income Statement Analysis

Values in billions INR

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Dr. Reddy's Laboratories Limited income statement - Annual data in billions INR
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Revenue & Gross Profit
Revenue	335.93	325.54	279.16	245.88	214.39	189.72	174.60	153.85	142.03	140.81
Cost of Revenue	158.67	135.11	115.56	106.54	100.55	86.65	80.59	70.42	65.72	62.45
Gross Profit	177.26	190.43	163.61	139.34	113.84	103.08	94.01	83.43	76.30	78.36
Operating Expenses
Research & Development	24.06	27.38	22.87	19.38	17.48	16.54	15.41	15.61	18.27	19.55
Selling, General & Administrative	106.76	93.87	77.20	68.03	62.08	54.65	0.00	48.89	46.91	46.37
Operating Expenses	127.14	118.59	98.30	82.20	77.92	78.80	78.02	62.54	64.39	64.86
Operating Income	50.12	71.84	65.31	57.14	35.92	24.28	15.99	20.89	11.92	13.50
Other Income/Expense
Interest Income	3.73	7.55	2.28	1.18	0.97	2.62	0.01	0.77	0.54	0.56
Interest Expense	3.74	-2.83	1.71	1.43	0.96	-0.97	0.01	0.89	0.79	0.63
Other Income/Expense	4.71	4.94	6.00	3.22	-3.63	2.13	2.04	1.56	2.42	1.16
Income
Income Before Tax	54.82	76.78	71.87	60.37	32.30	26.41	18.03	22.44	14.34	14.65
Income Tax Expense	12.35	19.54	16.19	15.30	8.73	9.18	-1.47	3.65	4.54	2.61
Net Income	42.85	56.54	55.68	45.07	23.57	17.24	19.50	18.80	9.81	12.04
Net Income - Continuous Operations	42.47	56.54	55.68	45.07	23.57	0.23	19.50	18.80	9.81	12.04
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	79.16	87.82	88.42	74.43	45.08	37.08	41.79	35.52	23.74	24.55
EBIT	58.56	72.01	73.58	53.42	33.26	24.28	-	-	-	-
Depreciation & Amortization	20.59	15.81	14.84	12.64	11.82	12.80	12.47	12.19	11.71	11.28
Earnings Per Share
Basic EPS	51.00	68.00	67.00	54.00	28.00	21.00	118.00	113.00	59.00	72.00
Diluted EPS	51.00	68.00	67.00	54.00	28.00	21.00	117.00	113.00	59.00	72.00
Basic Shares Outstanding	0.83	0.83	0.83	0.83	0.83	0.83	0.83	0.83	0.83	0.83
Diluted Shares Outstanding	0.83	0.83	0.83	0.83	0.83	0.83	0.83	0.83	0.83	0.83

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Dr. Reddy's Laboratories Financial Statements

What was Dr. Reddy's Laboratories's revenue in fiscal 2026?

Dr. Reddy's Laboratories reported revenue of INR 335.93B in fiscal 2026 (fiscal year ended Mar 31, 2026). That was up 3.2% from INR 325.54B a year earlier.

Is Dr. Reddy's Laboratories profitable?

Yes. Dr. Reddy's Laboratories earned net income of INR 42.85B in fiscal 2026, a net margin of 12.8%. In fiscal 2025 it earned INR 56.54B.

What is Dr. Reddy's Laboratories's operating margin?

Dr. Reddy's Laboratories's operating income was INR 50.12B on revenue of INR 335.93B in fiscal 2026, an operating margin of 14.9%, compared with 22.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition